Merck & Co., Inc. (MRK)
100.89
-1.38
(-1.35%)
USD |
NYSE |
Dec 04, 16:00
100.80
-0.09
(-0.09%)
Pre-Market: 05:45
Merck Shareholders Equity (Quarterly): 51.85B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.619B |
| Biogen, Inc. | 18.21B |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Cidara Therapeutics, Inc. | 422.39M |
| Moderna, Inc. | 9.33B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 129.55B |
| Total Liabilities (Quarterly) | 77.64B |
| Debt to Equity Ratio | 0.798 |
| Current Ratio | 1.661 |
| Net Debt Paydown Yield | -0.34% |